Li, A., Garcia, D. A., Lyman, G. H., & Carrier, M. (2018). Direct Oral Anticoagulant (DOAC) versus Low-Molecular-Weight Heparin (LMWH) for Treatment of Cancer Associated Thrombosis (CAT): A Systematic Review and Meta-Analysis. Thromb Res.
Citación estilo ChicagoLi, Ang, David A. Garcia, Gary H. Lyman, and Marc Carrier. "Direct Oral Anticoagulant (DOAC) Versus Low-Molecular-Weight Heparin (LMWH) for Treatment of Cancer Associated Thrombosis (CAT): A Systematic Review and Meta-Analysis." Thromb Res 2018.
Cita MLALi, Ang, David A. Garcia, Gary H. Lyman, and Marc Carrier. "Direct Oral Anticoagulant (DOAC) Versus Low-Molecular-Weight Heparin (LMWH) for Treatment of Cancer Associated Thrombosis (CAT): A Systematic Review and Meta-Analysis." Thromb Res 2018.